VolitionRx Limited
VNRX
$0.6358
$0.03986.68%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.31M | 1.23M | 1.29M | 976.50K | 797.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.31M | 1.23M | 1.29M | 976.50K | 797.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.31M | 1.23M | 1.29M | 976.50K | 797.00K |
| SG&A Expenses | 13.09M | 13.85M | 14.91M | 16.21M | 16.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.47M | 28.26M | 31.27M | 33.75M | 36.12M |
| Operating Income | -24.16M | -27.02M | -29.98M | -32.77M | -35.33M |
| Income Before Tax | -24.26M | -27.26M | -30.20M | -32.79M | -35.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.26 | -27.26 | -30.20 | -32.79 | -35.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 238.40K | 290.10K | 327.70K | 363.60K | 369.30K |
| Net Income | -24.02M | -26.97M | -29.87M | -32.42M | -34.91M |
| EBIT | -24.16M | -27.02M | -29.98M | -32.77M | -35.33M |
| EBITDA | -23.06M | -25.91M | -28.87M | -31.64M | -34.18M |
| EPS Basic | -0.27 | -0.31 | -0.36 | -0.40 | -0.46 |
| Normalized Basic EPS | -0.17 | -0.20 | -0.22 | -0.25 | -0.29 |
| EPS Diluted | -0.27 | -0.31 | -0.36 | -0.40 | -0.46 |
| Normalized Diluted EPS | -0.17 | -0.20 | -0.22 | -0.25 | -0.29 |
| Average Basic Shares Outstanding | 360.72M | 346.14M | 331.97M | 322.26M | 306.47M |
| Average Diluted Shares Outstanding | 360.72M | 346.14M | 331.97M | 322.26M | 306.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |